Asahi Kasei Corporation (AHKSY)
OTCMKTS · Delayed Price · Currency is USD
20.62
-0.76 (-3.55%)
Mar 12, 2026, 3:39 PM EST
Asahi Kasei Employees
Asahi Kasei had 50,352 employees as of March 31, 2025. The number of employees increased by 1,057 or 2.14% compared to the previous year.
Employees
50,352
Change (1Y)
1,057
Growth (1Y)
2.14%
Revenue / Employee
$384,988
Profits / Employee
$19,923
Market Cap
14.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 50,352 | 1,057 | 2.14% |
| Mar 31, 2024 | 49,295 | 398 | 0.81% |
| Mar 31, 2023 | 48,897 | 2,146 | 4.59% |
| Mar 31, 2022 | 46,751 | 2,254 | 5.07% |
| Mar 31, 2021 | 44,497 | 5,214 | 13.27% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Asahi Kasei News
- 10 hours ago - Asahi Kasei Begins Installation of Containerized Alkaline-Water Electrolyzer at Finland's First Commercial Hydrogen Refueling Station - Business Wire
- 14 days ago - Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris - Business Wire
- 14 days ago - Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases - GlobeNewsWire
- 15 days ago - Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds - Business Wire
- 22 days ago - Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases - Business Wire
- 6 weeks ago - Asahi Kasei Develops PFAS-Free PA66 Offering Low-Friction and High-Load Performance - Business Wire
- 2 months ago - ZOLL Strengthens Growth Trajectory for Asahi Kasei's Healthcare Sector with U.S. Launch of the Next-Generation LifeVest® WCD and Rollout of the Most Comfortable LifeVest Garment Ever, Reinforcing Position as Leader in WCD Category - Business Wire
- 2 months ago - Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark - Business Wire